Biodel Corporation - Independent Investigator Initiates Phase 1 Study of Biodel's Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
Links shared publicly online about this topic.
- 303total visits
Biodel Corporation - Independent Investigator Initiates Phase 1 Study of Biodel's Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
Biodel Corporation - Independent Investigator Initiates Phase 1 Study of Biodel's Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
View full resource at investor.biodel.com
Tags: Insulin, Phase 1 Clinical Trial
Most Recently Shared on May 10, 2011 at 4:52 pm By:
Biodel Corp. Phase 1 Study of Biodel's Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps: http://bit.ly/j57BbO
Advertisement
